MRIs Can Be Lethal! Heavy Metal Gadolinium Used for MRI Imaging Leaches Into Heart, Brain, Kidney, Bone and Can be Fatal

February 25, 2023

Excerpt:

“My friend died from gadolinium poisoning from MRIs and it was the most horrific death I’ve ever experienced.  First off, most doctors do not inform them of the dangers or what it really is and don’t test your body to see if you can chelate it and they also will deny that you were damaged from it if it happens and no one has been able to win this in or out of courts yet… My girlfriend had very good kidneys.

She had 7 years of horrific torture with severe burning where she said it felt like some one pulled back her skin and was pouring acid all over her and it crystalized all organs, veins, etc in her body.  Two of the most painful deaths you could have in one.  No drug could stop the pain.  The more MRIs you get the worse but even one can cause life long damage and can take a couple of years to activate the damage or pain.  After I seen what happened to her and since learned of others who burn constantly with no relief I could never suggest even one MRI with contrast no matter what you are going through cause it could not be worse then the consequences if you get contrast sickness.  She literally screamed almost 24 hours a day with only minor edge of pain relief for very short period of times and it of course makes a person extremely chemtrail and emf sensitive.  Not worth the risk under any circumstances in my experience.  I would rather die than live and deal with the torture she went through.  She finally died this past Fall as we pleaded for God to take her or heal her and he finally took her…Many doctors know about this, deny it publicly….”

From: A Tsiang

Subject: Update: Heavy Metal Gadolinium leaches into brain, kidney tissuefollowing MRI using Gd contrast. Some anecdotes. Gd Chelation with DTPA

=============================================================

1) Here’s the study that was published in Nature The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure | Scientific Reports (nature.com) that’s referenced in the medicalexpress article that was previously sent, forwarded in email below.  The article also contains a lot of images of gadolinium nanoparticles in tissue.  Excerpts:

Because gadolinium is toxic, magnetic resonance imaging contrast agents are proprietary aminopolycarboxylic acid chelates designed to bind the metal tightly and enhance renal elimination. Complications of MRI contrast agents include (sometimes fatal) gadolinium encephalopathy, acute kidney injury, gadolinium deposition disease/ symptoms associated with gadolinium exposure (SAGE)1 , and ‘nephrogenic’ systemic fbrosis1–5 . Exposure to any class of MRI contrast agent leads to the long-term retention of gadolinium6 . Residual gadolinium from MRI contrast agent exposure has been found in every vital organ, including the brain, in both patients and animal models7–11. Urine can contain gadolinium years after exposure to MRI contrast agents12. Our rodent models demonstrated the formation of gadolinium-rich nanoparticles in the kidney and skin following systemic MRI contrast agent treatment13–19. Gadolinium-rich densities have been found in neuronal cytoplasm and nuclei in the brains of individuals exposed to MRI contrast agents during the course of routine care11. The nanotoxicologic mechanisms of gadolinium-induced disease are poorly understood5,13–20. Our understanding of MRI contrast-induced complications is far from complete. These studies were conducted to characterize the composition of intracellular gadolinium-rich minerals that form after systemic MRI contrast agent treatment.

Concomitant with the Warburg effect in the kidney, systemic gadolinium-based contrast agent treatment induces dyslipidemia and insulin resistance14. Te impact of gadolinium-based contrast agent treatment in the liver was examined (Supplementary Fig. S5). Gadolinium increased intracellular triglycerides as assessed by oil red O staining. Electron microscopy revealed that gadolinium treatment increased unilamellar vesicles and reduced mitochondrial volume. Metabolomic analysis of the livers demonstrated alterations in metabolites associated with amino acid metabolism, glycogenesis, and glycolysis (Supplementary Table S1). These findings support the hypothesis that gadolinium-based contrast agents are not biologically inert5 .

(d) Peri-nuclear unilamellar vesicle and spiculated nanoparticles in a renal epithelial cell from a MRI contrast agent-treated female. Scanning transmission electron microscopy. Calibration bar=1 µm. (e) Magnifcation of the area in (d). Calibration bar=200 nm.

2) I got some responses from people on my list:

1) A radiologist: “Thank you for sending this out. I’ve been concerned about the use of Gadolinium as a contrast agent in MRI for a long time. In fact, one of my first publications was on the safety of mixing gadolinium and iodine contrast agent for MRI arthrograms. I was afraid that the gadolinium might dissociate. So now, 20 years later, the truth comes out!”

2) “You can also state you want an MRI without contrast dyes:  I did and prevailed but the physician literally had a screaming fit in the waiting room, in front of other patients, castigating me.

But I got no gadolinium or other contract dyes.  Based on my heavy metal activism re Mercury Amalgams: > 20 yrs, lecturing in US, Europe, Middle East.

Thanks for your message! “

3) “My friend died from gadolinium poisoning from MRIs and it was the most horrific death I’ve ever experienced.  First off, most doctors do not inform them of the dangers or what it really is and don’t test your body to see if you can chelate it and they also will deny that you were damaged from it if it happens and no one has been able to win this in or out of courts yet… My girlfriend had very good kidneys.

She had 7 years of horrific torture with severe burning where she said it felt like some one pulled back her skin and was pouring acid all over her and it crystalized all organs, veins, etc in her body.  Two of the most painful deaths you could have in one.  No drug could stop the pain.  The more MRIs you get the worse but even one can cause life long damage and can take a couple of years to activate the damage or pain.  After I seen what happened to her and since learned of others who burn constantly with no relief I could never suggest even one MRI with contrast no matter what you are going through cause it could not be worse then the consequences if you get contrast sickness.  She literally screamed almost 24 hours a day with only minor edge of pain relief for very short period of times and it of course makes a person extremely chemtrail and emf sensitive.  Not worth the risk under any circumstances in my experience.  I would rather die than live and deal with the torture she went through.  She finally died this past Fall as we pleaded for God to take her or heal her and he finally took her…Many doctors know about this, deny it publicly….”

3) Even in patients with normal kidney function, gadolinium has been deposited in the bone and brain, termed “gadolinium storage condition” .

The long-term and cumulative effects of retained gadolinium in the brain and elsewhere are not as yet understood.  This paper summarizes the various Gadolinium Toxicity conditions, from acute adverse reactions  to gadolinium deposition disease, and how they might be treated with chelating agent pentetic acid diethylenetriaminepentaacetic acid (DTPA),  Gadolinium toxicity and treatment – PubMed (nih.gov) Highlighted Copy is attached.  Here’s a paper on toxicity conditions Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update (ajnr.org)

Beware that if you go in for an MRI that calls for gadolinium [a heavy metal] contrast agent, that the heavy metal could end up in your kidney and brain tissue and NOT removed from your body.

Before going in for an MRI, find out if gadolinium contrast will be a part of the MRI, and ask your doctor if you really need it, especially if there are kidney concerns.

[If the MRI calls for a gadolinium contrast agent, you will be injected with a solution containing chelated gadolinium which is supposed to be excreted by your kidneys, HOWEVER, research is finding that it is breaking away from the chelating agents and ending up in kidney, brain, and other tissue.]

Also inform your doctor about these findings, that gadolinium ends up in your heart and other tissues and does not get completely excreted, as was thought.

Another problem is that the gadolinium is ending up in our water supply

Researchers find nanoparticles of a rare earth metal used in MRI contrast agents can infiltrate kidney tissue

by Michael Haederle, University of New Mexico Health Sciences Center

Intracellular gadolinium-rich nanoparticles in human kidneys because of routine diagnostic care. (a) Electron-dense nanoparticles in a kidney from a patient with a history of magnetic resonance imaging contrast agent exposure. This kidney was procured 17 days after magnetic resonance imaging contrast agent (20 mL). TEM, Hitachi HT7700. (b) The electron-dense nanoparticles are gadolinium rich. Embedded kidney from (a) (200 µm sections). XEDS line scanning was performed through an electron-dense nanoparticle. XEDS data revealed gadolinium, oxygen, and phosphorus. JEOL NEOARM 200 kV aberration-corrected scanning transmission electron microscope with dual EDS X-ray analysis system. Credit: Scientific Reports (2023). DOI: 10.1038/s41598-023-28666-1

Physicians routinely prescribe an infusion containing gadolinium to enhance MRI scans, but there is evidence that nanoparticles of the toxic rare earth metal infiltrate kidney cells, sometimes triggering severe side effects, University of New Mexico researchers have found.

In the worst cases, gadolinium, an element that has no biologic function, can trigger nephrogenic systemic fibrosis, a painful disease that affects the skin and organs and is often fatal.

In a new study published in Scientific Reports, a team led by Brent Wagner, MD, MS, associate professor in the UNM Department of Internal Medicine, describes the use of electron microscopy to detect tiny deposits of gadolinium in the kidneys of people who had been injected with contrast agents prior to their MRIs.

“These are nanoparticles,” Wagner said. “They’re actually forming nano material inside these cells.”

Gadolinium-based contrast agents were first introduced in the 1990s as MRI studies became more routine, he said. Gadolinium aligns with an MRI scanner’s powerful magnetic field, making for sharper images, but because of its toxicity, the metal must be tightly bound to chelating molecules so that it can be filtered through the kidneys and eliminated.

But the researchers have found that some gadolinium atoms can leach out of the contrast agents into the kidneys and other tissues, Wagner said. The effect was found in both rodent and human specimens, he said.

“We got five tissues from patients with histories of MRI contrast exposure, and another five from control patients who were contrast-naive, and I was astounded, because all five of those exposed to the contrast agent had gadolinium in them.”

Contrast agents containing gadolinium are used in about 50% of MRI scans, Wagner said. A major question is why some people develop the disease, but most people who are exposed never exhibit negative symptoms.

“Patients have gotten the full-blown disease after just a single dose,” he said. “Some have gotten disease eight years after exposure.” There are even reports of people who received heart or kidney transplants developing symptoms.

The odds of developing disease appear to increase with greater exposure to the contrast agent and as gadolinium deposits build up in tissues, Wagner said. “There are people who get five doses, and then you can start detecting the gadolinium inside the brain when you do an MRI without any contrast.”

It’s unclear how some of the gadolinium detaches from the chelating molecules, he said.

“The big question is how does this contrast agent liberate the gadolinium and modulate its deposition in the cell,” said Wagner, who also serves as director of the Kidney Institute of New Mexico and Renal section chief for the New Mexico Veterans Affairs Health Care System.

The study brought together collaborators from the UNM Department of Earth and Planetary Sciences, the UNM Department of Mathematics and Statistics, the Chan Zuckerberg Initiative, the New Mexico VA Health System and the Center for Integrated Nanotechnologies at Los Alamos National Laboratory and Sandia National Laboratories.

Wagner voiced concerns about the widespread use of gadolinium-based contrast agents, suggesting that many physicians might not be aware of the risks. “Quite often, contrast is given where it’s not needed—or maybe you don’t even need an MRI.”

An additional concern is that gadolinium seems to be finding its way into the environment. Because the MRI contrast agent is expelled through urine, it released into sewer systems, but wastewater treatment plants aren’t equipped to remove it, he said.

Gadolinium levels have grown twenty-fold in the San Francisco Bay, and in Germany gadolinium can be detected in soft drinks made from tap water. The same phenomenon is evident in New Mexico, he said.